Co-Authors
This is a "connection" page, showing publications co-authored by Neal Silverman and Ravi Bharadwaj.
Connection Strength
2.196
-
Bharadwaj R, Jaiswal S, Silverman N. Cytosolic delivery of innate immune agonists. Trends Immunol. 2024 Dec; 45(12):1001-1014.
Score: 0.982
-
Bharadwaj R, Lusi CF, Mashayekh S, Nagar A, Subbarao M, Kane GI, Wodzanowski KA, Brown AR, Okuda K, Monahan A, Paik D, Nandy A, Anonick MV, Goldman WE, Kanneganti TD, Orzalli MH, Grimes CL, Atukorale PU, Silverman N. Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity. Immunity. 2023 05 09; 56(5):998-1012.e8.
Score: 0.881
-
Bharadwaj R, Anonick MV, Jaiswal S, Mashayekh S, Brown A, Wodzanowski KA, Okuda K, Silverman N, Grimes CL. Synthesis and validation of click-modified NOD1/2 agonists. Innate Immun. 2023 Nov; 29(8):186-200.
Score: 0.227
-
Gupta A, Dhiman A, Sood A, Bharadwaj R, Silverman N, Agrawal G. Dextran/eudragit S-100 based redox sensitive nanoparticles for colorectal cancer therapy. Nanoscale. 2023 Feb 16; 15(7):3273-3283.
Score: 0.054
-
Sood A, Gupta A, Bharadwaj R, Ranganath P, Silverman N, Agrawal G. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer. Carbohydr Polym. 2022 Oct 15; 294:119833.
Score: 0.052